The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus-Reference-Cited by-同舟云学术

The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus

Published:2015-10-31 Issue:1 Volume:14 Page:
ISSN:1475-2840
Container-title:Cardiovascular Diabetology
language:en
Short-container-title:Cardiovasc Diabetol

Author:

Mátyás Csaba,Németh Balázs Tamás,Oláh Attila,Hidi László,Birtalan Ede,Kellermayer Dalma,Ruppert Mihály,Korkmaz-Icöz Sevil,Kökény Gábor,Horváth Eszter Mária,Szabó Gábor,Merkely Béla,Radovits Tamás

Funder

Országos Tudományos Kutatási Alapprogramok (HU)

János Bolyai Research Scholarship of the Hungarian Academy of Sciences

European Social Fund (BE)

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1186/s12933-015-0309-x

Reference42 articles.

1. Huynh K, Bernardo BC, McMullen JR, Ritchie RH. Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways. Pharmacol Ther. 2014;142:375–415.

2. Radovits T, Korkmaz S, Loganathan S, et al. Comparative investigation of the left ventricular pressure-volume relationship in rat models of type 1 and type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol. 2009;297:H125–33.

3. Radovits T, Bomicke T, Kokeny G, et al. The phosphodiesterase-5 inhibitor vardenafil improves cardiovascular dysfunction in experimental diabetes mellitus. Br J Pharmacol. 2009;156:909–19.

4. Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care. 2001;24:5–10.

5. Joffe II, Travers KE, Perreault-Micale CL, et al. Abnormal cardiac function in the streptozotocin-induced non-insulin-dependent diabetic rat: noninvasive assessment with doppler echocardiography and contribution of the nitric oxide pathway. J Am Coll Cardiol. 1999;34:2111–9.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Possible retinotoxicity of long-term vardenafil treatment;Experimental Eye Research;2024-06

2. Role and molecular mechanisms of SGLT2 inhibitors in pathological cardiac remodeling (Review);Molecular Medicine Reports;2024-03-11

3. Empagliflozin treatment of cardiotoxicity: A comprehensive review of clinical, immunobiological, neuroimmune, and therapeutic implications;Biomedicine & Pharmacotherapy;2023-12

4. Modulation of the nitric oxide/cGMP pathway in cardiac contraction and relaxation: Potential role in heart failure treatment;Pharmacological Research;2023-10

5. BNP protects against diabetic cardiomyopathy by promoting Opa1-mediated mitochondrial fusion via activating the PKG-STAT3 pathway;Redox Biology;2023-06